Evidence map›Paper›PMID 31220287›Full record

ArticleThe Journal of clinical endocrinology and metabolism2019

Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.

Laila A Gharzai, Michael D Green, Kent A Griffith, Tobias Else, Charles S Mayo, Elizabeth Hesseltine, Daniel E Spratt, Edgar Ben-Josef, Aaron Sabolch, Barbara S Miller and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2024
    Review
  13. Review
  14. Article
  15. Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Laila A GharzaiDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Michael D GreenDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Kent A GriffithDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Tobias ElseDepartment of Endocrinology, University of Michigan, Ann Arbor, Michigan.
Charles S MayoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Elizabeth HesseltineDepartment of Endocrinology, University of Michigan, Ann Arbor, Michigan.
Daniel E SprattDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Edgar Ben-JosefDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Aaron SabolchDepartment of Radiation Oncology, Kaiser Permanente, Portland, Oregon.
Barbara S MillerDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.
Francis WordenDepartment of Internal Medicine, Division of Medical Oncology, University of Michigan, Ann Arbor, Michigan.
Thomas J GiordanoDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.
Gary D HammerDepartment of Endocrinology, University of Michigan, Ann Arbor, Michigan.
Shruti JollyDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
University of Michigan–Ann Arbor · USKaiser Permanente · USUniversity of Pennsylvania · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
NCI NIH HHS P30 CA046592
6 · The paper itself

Abstract

contextAdrenocortical carcinoma (ACC) is a rare malignancy with high rates of recurrence and poor prognosis. The role of radiotherapy (RT) in localized ACC has been controversial, and RT is not routinely offered.

objectiveTo evaluate the benefit of adjuvant RT on outcomes in ACC.

designThis is a retrospective propensity-matched analysis.

settingAll patients were seen through the University of Michigan's Endocrine Oncology program, and all those who underwent RT were treated at the University of Michigan.

participantsOf 424 patients with ACC, 78 were selected; 39 patients underwent adjuvant radiation.

interventionAdjuvant RT to the tumor bed and adjacent lymph nodes. MAIN OUTCOMES MEASURES: Time to local failure, distant failure, or death.

resultsMedian follow-up time was 4.21 years (95% CI, 2.79 to 4.94). The median radiation dose was 55 Gy (range, 45 to 60). The 3-year overall survival estimate for patients improved from 48.6% for patients without RT (95% CI, 29.7 to 65.2) to 77.7% (95% CI, 56.3 to 89.5) with RT, with a hazard ratio (HR) of 3.59 (95% CI, 1.60 to 8.09; P = 0.002). RT improved local recurrence-free survival (RFS) from 34.2% (95% CI, 18.8 to 50.3) to 59.5% (95% CI, 39.0 to 75.0), with an HR of 2.67 (95% CI, 1.38 to 5.19; P = 0.0035). RT improved all RFS from 18.3% (95% CI, 6.7 to 34.3) to 46.7% (95% CI, 26.9 to 64.3), with an HR 2.59 (95% CI, 1.40 to 4.79; P = 0.0024).

conclusionsIn the largest single institution study to date, adjuvant RT after gross resection of ACC improved local RFS, all RFS, and overall survival in this propensity-matched analysis. Adjuvant RT should be considered a part of multidisciplinary management for patients with ACC.

Indexed as

AdolescentAdrenal Cortex NeoplasmsAdrenocortical CarcinomaAdultAgedCase-Control StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisRadiotherapy, AdjuvantRetrospective StudiesSurvival Rate

Identifiers

PMID31220287
PMCPMC8926022
OpenAlexW2937296959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.